HyTest Success Built on Science and Commitment


Success built on
science and commitment

Science-based development of immunological reagents for the IVD industry and research community

 

HyTest is Iso 9001 Certified

 

Quality from
development to deliveries

        - Safe and secure deliveries worldwide
        - ISO9001  certified operations 

 

HyTest World Class Service


World class service

  • Personal service

  • Technical support – we develop and know our products

We are committed to offer best solutions to our customers

PCT Products

HyTest provides high quality PCT products to support your assay development.

D-dimer antibodies

Our D-dimer antibody range is suitable for development of sensitive D-dimer assays for different test platforms.

PAPP-A products

Careful selection of antibodies is needed in order to guarantee accurate measurements of PAPP-A.

Troponin I Assay

Development of HyTest troponin I antibodies is a result of decades' research and development.

Antibody development and production for cardiac markers area

HyTest offers innovative solutions for assay development and research applications by providing high-quality immunological reagents in such areas as cardiac markers, Troponin I and Troponin T, infectious disease antibodies and autoimmune disease reagents.

HyTest R&D specialists maintain close ties with the scientific community and engage in joint research with Finnish and international academic diagnostic research organizations. This is why HyTest is having success in the field of quality antibody production and is number one choice as a cardiac marker supplier.
.

Get the latest news
and offers!

Order HyTest Newsletter

HyTest eNews 2012 (-one group)

Stay informed on our latest news!

Let's connect:

HyTest Twitter

News

14-05-2013 HyTest anti-cTnI antibodies utilized in a novel, highly sensitive cTnI assay

LambdaGen’s new diagnostic platform allows rapid and reproducible quantification of cTnI from whole serum. 

06-05-2013 HyTest awarded an Achiever Certificate

Again this year we had the pleasure to receive the Kauppalehti Achiever Certificate.

29-11-2012 HyTest's Annual Result 2012

HyTest’s revenue at the end of October for the fiscal year 2011-2012 year was 12.7 million euros. Growth over the previous year was record high 25% despite the volatile economy in the EU.

29-11-2012 Monoclonal antibody to glycated hemoglobin (HbA1c)

HyTest offers now a monoclonal antibody specific to HbA1c that may be used to develop an ELISA, lateral-flow- or a turbidometric assay.